Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

02 Jun 2026 - 04 Jun 2026
17 Jun 2026 - 19 Jun 2026
05 Oct 2026 - 06 Oct 2026

Test Identifies Aspirin Resistance in Heart Patients

By HospiMedica staff writers
Posted on 28 Mar 2001
A new diagnostic test identifies heart patients who are nonresponsive to aspirin, so doctors can prescribe alternate anti-platelet drugs.

Recent studies have reported that up to 15-20% of all heart patients currently taking aspirin as a preventive tool do not respond appropriately to aspirin's ability to reduce platelet function or they have become resistant to aspirin over time. More...
The new assay enables doctors to detect and monitor a heart patient's response to aspirin when used for the prevention of heart attacks and strokes. The test could also be used to determine compliance in patients on an aspirin regimen.

The test, called Aspirincheck, requires only a urine sample and provides results in two days. It was developed by Esoterix Coagulation (Aurora, CO, USA), which provides technology-based laboratory services and information.

"Tradition dictates that we test to monitor the effectiveness of long-term medication such as lipid-lowering drugs, so it makes sense that we start testing to monitor aspirin's effectiveness as well,” said Alexander Duncan, M.D., of Emory University (Atlanta, GA, USA).



Related Links:
Esoterix Coagulation

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
12-Channel ECG
CM1200B
Hybrid Arch Device
Neo EDE
New
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Elyra TFL System uses thulium fiber laser technology for efficient stone dusting and reduced stone migration, with an air-cooled design for quieter, more compact operation (photo courtesy of BD

BD Launches Elyra Laser Platform for Kidney Stone and Soft Tissue Procedures

BD (Becton, Dickinson and Company) has introduced the Elyra Thulium Fiber Laser (TFL) System, an advanced laser platform developed to complete its kidney stone care portfolio for urology teams.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.